Ruxolitinib is an effective steroid sparing agent in bronchiolitis obliterans due to chronic graft-versus-host-disease.

Bone Marrow Transplant

Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kansas, 3901 Rainbow Blvd. MS 3007, Kansas City, KS, USA.

Published: June 2020

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0662-6DOI Listing

Publication Analysis

Top Keywords

ruxolitinib effective
4
effective steroid
4
steroid sparing
4
sparing agent
4
agent bronchiolitis
4
bronchiolitis obliterans
4
obliterans chronic
4
chronic graft-versus-host-disease
4
ruxolitinib
1
steroid
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!